Our people

ATS recognizes curious minds for advances in respiratory care

Patients & consumers

Meet Jennifer: a science researcher whose quest became her own health

As a biomedical researcher at a major medical institution, Jennifer’s happiest days are spent reading, learning, and working on discovering something that will help improve people’s health. While her research includes rare diseases, she never imagined that she’d one day put her skills to use on herself, to unlock the strange mystery going on inside her body.

Innovation

Lupus: the search for a cure continues

Lupus is a challenge, with doctors and patients facing an ongoing battle to manage this chronic, life-threatening condition. So, to understand it better we recently explored lupus management in a global survey of more than 500 specialist lupus doctors (mainly rheumatologists) and patients.

Access to healthcare

Why are we fighting malaria in the lab and on the ground?

Despite progress to fight malaria, millions of people continue to suffer every year. We’re helping by researching medicines and vaccines, supporting community prevention and health worker training and strengthening access to medicines.

Innovation

How do consumer insights fuel our innovation?

By asking our consumers what matters to them, we can keep innovating and evolving our products. Importantly, this is not just about using our science to improve the products themselves – but also how the product is delivered.

Our people

Who was Percy Julian?

Our people

Linking a chapter of GSK history to the fight for freedom

Patients & consumers

Controlled asthma, to me, means freedom

Patients give a voice to living with asthma in this video from GSK and the CHEST Foundation.

Patients & consumers

If you can’t breathe, you won’t be able to play the tuba

It may seem obvious, but “if you can’t breathe, you’re not going to able to play the tuba very effectively,” said Brendan Bohnhorst, from Grand Rapids, Michigan, USA.

Our people

The journey from research to respiratory treatment

Meet Elaine Jones. She heads up a team that follows each step of a respiratory medicine’s journey from research to becoming a treatment.

Patients & consumers

Veterans continue to fight for respiratory health

After serving their country, many veterans face long-term health challenges but sometimes symptoms may not appear for decades and aren’t quickly recognized, aggravating their condition.

Patients & consumers

A birthday wish: for all COPD patients to live every breath

Our people

What I know about asthma… then and now.

Innovation

Welcome to the golden age of vaccine innovation

With vaccines widely available for many of the most common childhood illnesses, like measles and mumps, many people think that the golden age of vaccine development has passed. Our head of Vaccines R&D, Dr Emmanuel Hanon, thinks they’re wrong.

Our people

Crossing items off my bucket list, one breath at a time

Karen Scheffler, Manager, Sales Force Effectiveness, shares her personal journey in the pursuit of better breathing.

Patients & consumers

Hyung makes sense of what consumers want

We spoke to one of our Principal Sensory Scientists, Hyung Chang – based at our Consumer Sensory labs in Warren, New Jersey.

Our people

Breathing life into an idea for a respiratory medicine

Meet Mark Luttmann, one of our respiratory pioneers. Mark was on the drug discovery team for a key component of several of our COPD medications.

Our people

Jamie's story: I control my asthma, it doesn’t control me

Our people

Thank you for calling GSK. Meet Paul, the voice at the end of the line.

Patients & consumers

Don’t mind me. I’m just making sure I can breathe.

For some, breathing easy sounds simple – it just happens. But for Sarah and for millions of others like her, breathing can be a daily struggle.

Our people

Brian Johns goes boldly for people living with HIV

There are over 36 million people living with HIV around the world with an estimated 70% who are not adequately treating the virus.

Our people

How curious minds saved a medicine from being left in the lab

See how Steve and his team refined their scientific focus in order to deliver our first biologic respiratory medicine.

Access to healthcare

Pricing our medicines to help ensure patient access

We know there is significant frustration in the US regarding the cost of healthcare – including prescription medicines. We take this very seriously, as evidenced by our pricing track record.

Access to healthcare

Helping patients in need

How we do business

Changing the way we do business

How we do business

Fast-tracking our response to pandemics

In the wake of global pandemics such as Ebola and Zika, there is consensus that the world needs to be better prepared.

How we do business

Putting it plainly

In our opinion, being transparent is not a path to failure — it is a source of strength.

How we do business

Hunting for energy savings

You never know what you might find when you hunt for waste.

How we do business

Creating bricks and benches out of medical waste

Instead of being incinerated, medical lab waste at our Upper Providence site is being upcycled into bricks and benches.

How we do business

Evolving our graduated approach to intellectual property

Our people

Building future leaders

Our people

Designing inspiring and healthy workplaces

As a healthcare company, we focus on how we can best support the wellbeing of patients, consumers, and our employees.

Innovation

On target for a new era of drug discovery?

Almost half a century ago, the world entered an apparent golden era of drug discovery. Driven by a rapidly advancing understanding of biological processes in the body and medicinal chemistry, a generation of game-changing new medicines emerged.

Patients & consumers

GSK IMPACT Awards: 20 years of healthy communities

The GSK IMPACT Awards recognize local nonprofit organizations in our hometowns of Greater Philadelphia, PA and the Triangle Region, NC that are working to improve health hand-in-hand with the community.

How we do business

Buyer beware: importing drugs comes with big risks

At first blush, importing medicines sounds great – a patient without insurance or facing a high deductible or co-pay may find the prices quite attractive. But importation carries major risks.

How we do business

How doctors and insurers get information about medicines

Our people

The gift of time: increased parental leave

Our people

Work Together, Give Together

One way GSK supports communities is the through the Orange Day initiative, allowing GSK employees to take a paid day off to volunteer for a chosen community project, nonprofit organization or cause which they support.

Our people

Engineers as leaders: The art of the possible over the probable

GSK's David Lynch reflects on his career, the role of engineering in healthcare, and the path to leadership in the profession.

Patients & consumers

Living with COPD Every Day: Sean’s Story

Pinch your nose and try breathing through a straw? Not so easy, right?

Our people

Making healthy cool in school through Get HYPE Philly!

Priscilla is quick to tell you she’s not looking forward to this school year; how her sister drives her nuts; and how doubling up on algebra and geometry is going to make this year tougher than any before.

Patients & consumers

Whooping cough: confronting the hidden risk to infants

Our people

GSK archives: William Allen, scientist, businessman, abolitionist

Patients & consumers

Inspiring Students through STEM Education Programs

In the next five years, the US will add eight million jobs in STEM fields. Yet more than 20% of all students, and half of all minority students, drop out of school before graduation.

Innovation

Scientists or detectives? Seeking new clues in COPD

We continuously strive for new opportunities to evolve our understanding of COPD that will help us meet individual patient needs.

How we do business

Helping to Change the World

FORTUNE Magazine published its 2016 list of companies that are changing the world, and we are honored to be ranked #1.

Our people

GSK and The National Museum of African American History and Culture

We are incredibly proud to be a Founding Donor of The National Museum of African American History and Culture in the Smithsonian Institution.

Innovation

Can iPhones change how we monitor and improve patient health?

Patients & consumers

Take a Breather: 8 Fast Facts on Severe Asthma

Our people

Changing gears in a scientific career

GSK medic, Emma Hilton, tells us about her career in science and how she makes hard work easier.

Our people

Persevere to accelerate your career success: lessons from an engineer

I was born and raised in Mexico and grew up loving both science and people. This love drove me to study Chemical Engineering which eventually helped me become an engineer, a line manager, and, currently, the director of the Future Leaders Program in Global Manufacturing and Supply at GSK.

How we do business

Letting the sunshine in – transparency that’ll grow trust

Transparency for the sake of transparency seems a fruitless endeavor. Done right, however, it can be very powerful in strengthening relationships and forging new partnerships.

Patients & consumers

The power of advocacy: coming together for the patient

When it comes to patient care, information sharing is vital – between the patient and doctor, and among multiple members of the care team. But did you ever think that information sharing is equally important during the research process, long before a new medical therapy reaches patients?

Access to healthcare

Global mission, local impact

Our people

From academia to industry: a new challenge

Our people

Andy Dundon: the design behind the device

Andy Dundon leads our Research and Development (R&D) Device Engineering team in Ware, UK. His team focuses on ways to improve the design of our drug delivery devices, including through the use of digital technologies.

Innovation

Turning the tide on antibiotic resistance

Picture a world where people routinely die from minor infections, where invasive surgery like organ transplants can’t be performed because it’s too risky, and where hospital wards are breeding grounds for disease.

Our people

Clinical Trials: Q&A with Murray Stewart

Dr. Murray Stewart is our Chief Medical Officer. In this role, he is the most senior physician at GSK, and has overall responsibility for patient well-being across vaccines, pharmaceutical and consumer medicines. He also oversees medical ethics and integrity.

Patients & consumers

Beyond Breathing: When Is Asthma Really Under Control?

Often, despite trying many different asthma management techniques – from medication to avoiding triggers – patients have told me they were still experiencing asthma symptoms on a regular basis.

Patients & consumers

GSK Uncovers The State of Uncontrolled Asthma in America

Our people

Respiratory disease: why we want to make a difference

Access to healthcare

In Africa, markets matter for a healthy society

When it comes to improving access to healthcare in Africa, markets matter. From pharmaceutical companies to small clinics, an interconnected private market complements public sector services to help patients receive the healthcare they need, when and where they need it.

Our people

Safety first: Employee wellbeing rides on it

Every day, Rajendra rides his motorcycle 30 kilometers to and from the area he covers, and also uses it to travel to meet healthcare professionals.

Our people

Beyond manufacturing in Chile and Madagascar

In 2015, GSK Vaccines sent two vaccine manufacturing teams to South America and Africa to better understand the impact of their daily work.

Our people

Why I fight malaria: Laura's story

Laura is a scientist and a mom. Here she describes what motivates her to fight against malaria.

Our people

Making the global goals our business

Patients & consumers

8 simple activities that may not be so simple when you have severe asthma

Innovation

Take a deep breath - your lung microbiome will appreciate it

Scientists are discovering just how important microbes are in maintaining our respiratory health and immunity

Innovation

Unlocking the secrets of the immune system to tackle disease

As science evolves we are learning that the immune system does so much more than protect us from an outside attack.

Patients & consumers

Fostering Wellness initiative: young people lead the way!

Jack Bailey, President GSK US Pharmaceuticals, and North Carolina Governor Pat McCrory and others announced the winners of our $1 million GSK IMPACT Grant.

Our people

My International Women's Day advice is for everyone

As a physician, a senior executive, a researcher and a parent, I play many roles – but I don’t often stop to think about my gender.

Innovation

Harnessing the body’s electrical language to treat disease

Our people

Rare Disease Day 2016: What it means to us

Our people

On the job with GSK's medical device research team

A mechanical engineering graduate on a GSK Future Leaders Programme is helping to develop user-friendly devices to administer treatments safely.

Our people

Volunteering in Kenya: a once in a lifetime experience

PULSE volunteer, Mizanul Islam shares his experience of working with Save the Children in Bungoma County, Kenya for six months in 2015.

Our people

Treating malaria: Making a change from the inside

Allan Pamba recalls his experiences as a doctor in Kenya and why he decided to work for ‘the enemy' - a pharmaceutical company.

Our people

A partnership perspective with Simon Wright

Simon Wright, Head for Child Survival at Save the Children, talks about how we’re working together to make sure the health needs of the world’s poorest children are at the top of everyone’s agenda.

Patients & consumers

The Power of 24hrs

Access to healthcare

TEDMED 2015: An interview with curator, Christine McNab

Access to healthcare

TEDMED 2015: Art, inspired by vaccination

There are surprising similarities between an artist beginning a new work and a researcher on a quest to develop a vaccine.

Access to healthcare

Giving mothers and babies a healthier start

Find out how our scientists have adapted an ingredient from a GSK mouthwash into a potentially life-saving gel for newborns in developing countries.

Our people

War and peace: Ivo, Nobel prize winner

In the world of business—and scientific research—war metaphors abound. “Hitting our targets.” “Fighting cancer.” What we don’t see are many comparisons to peacekeeping.

Our people

Changing Lives

The PULSE Volunteer program is GSK’s flagship skills-based volunteering initiative. Launched in 2009, PULSE serves as a matchmaker for GSK and the non-profit sector – connecting the skills of our high-performing employees with the pressing needs of our non-profit partners.

Innovation

Rare diseases: Q&A with Martin Andrews

How we do business

The hope for a cure for HIV/AIDS in our lifetime

Patients & consumers

Every breath you take: Alison’s story

Imagine if every breath you took was a struggle; imagine waking up in the night short of breath and wheezing.

Innovation

Cell and gene therapy: a new era of medicine

Since the structure of DNA was discovered by James Watson and Francis Crick in 1953, significant advances have been made in our understanding of diseases caused by faulty genes.

Innovation

The race to richer data in clinical trials

That’s why we’re working with a range of partners, including the McLaren Technology Group and Medidata, to find new ways to use biosensors and mobile health platforms to improve patient care.

How we do business

Switching to consumer choice: medicines for everyday health

How our consumer strategy is improving quality of life and access to established medicines

Access to healthcare

Our humanitarian response to the Ebola outbreak

Access to healthcare

Malaria: life cycle of a parasite

How we do business

Changing the way we work with healthcare professionals

Putting patients’ interests at the heart of every decision.

How we do business

Flonase: the journey from prescription to OTC

Switching a product from a prescription medicine to over the counter (OTC) is nothing to sniff at.

Access to healthcare

The fight against malaria

By the time the second hand on your watch has circled its dial, a child will have died of malaria.

Patients & consumers

Clinical trials: a patient's view

In 2009 John Patrick Murphy, a 68 year old trial lawyer from Colorado, took a run-of-the-mill fall, which caused him a great deal of pain in his leg.

Innovation

Epigenetics: turn-ons and turn-offs

Patients & consumers

Science of a different stripe

Innovation

Neuroscience: on the brain

The number of people living with dementia worldwide is set to treble by 2050 to 135 million, according to the World Health Organization.

Innovation

Can mosquitoes prevent malaria?

Find out how we are breeding 2,000 mosquitoes every week in the search for anti-malarial medicines.

Patients & consumers

Eggs in manufacturing

Chickens. Where would we be without them? Well for one thing, we wouldn’t have nearly as many influenza vaccines as we need.

Innovation

Bacteria: friends or foes?

What if instead of trying to see off the bugs, we harnessed them and made them work for us, instead of against us?

Innovation

Data transparency

Innovation

Inside the open lab

How we do business

Green chemistry

Our scientists aim to discover new medicines while reducing the environmental impact of their manufacture, supply and use.

Access to healthcare

Collaborating to improve patient care

Over the past few years, we’ve seen a significant shift with organizations and individuals across the US healthcare system coming together to deliver, and reward, better value in healthcare.

Patients & consumers

Struggling for breath

Claudette, 54, stops on the short walk between the bus stop and her nearby apartment. She needs to catch her breath. She is a grandmother of two, and suffers from COPD.

How we do business

Biosecurity and pandemic preparedness

Our global commitment to helping ensure health for all is built on developing innovative medicines and vaccines and making sure they’re accessible to people around the globe.

Back to top